Medical Equipment

Cell-Free DNA (cfDNA) Blood Collection Tube Market Analysis Highlighting Growth Drivers And Outlook

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Cell-Free DNA (cfDNA) Blood Collection Tube Market Progress Between 2026 And 2030?

The cell-free DNA (cfDNA) blood collection tube market has seen rapid expansion in recent years. It is anticipated to increase from $1.33 billion in 2025 to $1.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. The historical growth of this market can be linked to factors such as a rising need for prenatal testing, the development of cancer diagnostics, the integration of cfDNA into research, advancements in laboratory automation, and the growth of diagnostic centers.

The cell-free dna (cfdna) blood collection tube market size is projected to experience significant expansion in the coming years, with expectations to reach $2.49 billion by 2030, progressing at a compound annual growth rate (CAGR) of 13.3%. This projected growth throughout the forecast period stems from innovations in blood tube preservatives, the integration with AI diagnostics, the expanding liquid biopsy market, an increase in clinical trials, and growing demand in emerging markets. Noteworthy trends for this period include enhanced sample preservation, integration with liquid biopsy platforms, standardized blood collection protocols, automation in sample processing, and high-stability tube designs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28160&type=smp

Which Key Drivers Are Affecting The Cell-Free DNA (cfDNA) Blood Collection Tube Market Development?

A future expansion of the cell-free DNA (cfDNA) blood collection tube market is anticipated, driven by the growing incidence of respiratory disorders. These disorders are health issues impacting the lungs and associated respiratory components, which compromise effective breathing, oxygen supply to the blood, or carbon dioxide expulsion. The rise in these conditions is substantially linked to air pollution, a factor that inflames airways, diminishes lung capacity, and elevates the likelihood of ailments such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). In the context of respiratory disorder management, cell-free DNA (cfDNA) blood collection tubes facilitate the identification of genetic mutations, tracking of disease advancement, and evaluation of treatment outcomes via a straightforward blood examination, consequently diminishing the necessity for intrusive lung biopsies. As an illustration, the Centers for Disease Control and Prevention, a US-based government agency, reported in December 2024 that respiratory syncytial virus (RSV) led to an estimated 17,000 to 34,000 hospitalizations between October 1 and November 30, 2024. Consequently, the growing incidence of respiratory disorders is propelling the expansion of the cell-free DNA (cfDNA) blood collection tube market.

Which Segment Types Are Examined In The Cell-Free DNA (cfDNA) Blood Collection Tube Market Segment Study?

The cell-free dna (cfdna) blood collection tube market covered in this report is segmented –

1) By Type: 5ml, 10ml

2) By Sample Type: Plasma, Serum, Whole Blood

3) By Application: In Vitro Diagnostics, Scientific Research

4) By End-User: Diagnostic Laboratories, Hospitals Or Clinical Centers, Genetic Diagnostic Labs, Cancer Research Centers, Research And Development Institutions, Conventional Diagnostic Centers

Subsegments:

1) By 5 mL: Single Use Tube, Vacuum Blood Collection Tube, Gel Separator Tube

2) By 10 mL: Double Draw Tube, High Volume Collection Tube, Anticoagulant Treated Tube

What Trends Are Transforming The Cell-Free DNA (cfDNA) Blood Collection Tube Market?

Major companies operating in the cell-free DNA (cfDNA) blood collection tube market are concentrating on automating cfDNA extraction to elevate workflow efficiency. The automation of cfDNA extraction refers to the deployment of advanced robotic instruments and standardized methods to isolate cell-free DNA from blood samples with minimal human involvement, thereby enhancing efficiency, accuracy, and consistency while decreasing processing time and minimizing human errors. For instance, in September 2023, Yourgene Health plc, a UK-based molecular diagnostics company, introduced the MagBench Automated DNA Extraction Instrument and Kit, providing a fast, straightforward, and cost-effective bench-top robotic solution tailored for cell-free DNA extraction in non-invasive prenatal testing (NIPT) workflows. This launch aims to strengthen automation in NIPT workflows by delivering superior throughput, reproducibility, and reliability in cfDNA extraction, concurrently reducing manual input and operational expenditures.

Which Players Are Part Of The Competitive Landscape Of The Cell-Free DNA (cfDNA) Blood Collection Tube Market?

Major companies operating in the cell-free dna (cfdna) blood collection tube market are Roche Holding AG, Thermo Fisher Scientific Inc., Becton Dickinson (BD), Qiagen N.V., SARSTEDT AG & Co. KG, Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

Get The Full Cell-Free DNA (cfDNA) Blood Collection Tube Market Report:

https://www.thebusinessresearchcompany.com/report/cell-free-dna-cfdna-blood-collection-tube-global-market-report

Which Region Is The Top Contributor To The Cell-Free DNA (cfDNA) Blood Collection Tube Market By Share?

North America was the largest region in the cell-free DNA (cfDNA) blood collection tube market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-free dna (cfdna) blood collection tube market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell-Free DNA (cfDNA) Blood Collection Tube Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=28160&type=smp

Browse Through More Reports Similar to the Global Cell-Free DNA (cfDNA) Blood Collection Tube Market 2026, By The Business Research Company

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Surface Vision And Inspection Market Report 2026

https://www.thebusinessresearchcompany.com/report/surface-vision-and-inspection-global-market-report

Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795